CausalSentinel

Protein Dossier — SHBG (Sex hormone-binding globulin)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Body fat 0.106 0.0266 7.34e-05 Wald ratio 1 cis NA
HDL cholesterol 0.0893 0.0243 2.40e-04 Wald ratio 1 cis NA
Hirschsprung’s disease 2.19 0.606 2.97e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: deep venous thrombosis (dvt) 0.221 0.0646 6.33e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypertension 0.0601 0.0182 9.35e-04 Wald ratio 1 cis NA
Cardioembolic stroke -0.497 0.162 0.00212 Wald ratio 1 cis NA
Alcohol intake frequency -0.0494 0.0167 0.00314 Wald ratio 1 cis NA
Platelet count -6.61 2.25 0.00323 Wald ratio 1 cis NA
Diagnoses - main ICD10: H25 Senile cataract 0.265 0.1 0.00811 Wald ratio 1 cis NA
Creatinine (enzymatic) in urine -0.027 0.0108 0.0125 Wald ratio 1 cis NA
Birth length 0.128 0.0523 0.0148 Wald ratio 1 cis NA
Haemoglobin concentration 0.0715 0.0294 0.0152 Wald ratio 1 cis NA
…and 112 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4929_55_1 SHBG Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

210 association rows across 88 traits (202 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Sex hormone-binding globulin levels 2e-3373 rs6258 34 GCST90025958 no MR -> candidate analysis
Sex hormone-binding globulin levels adjusted for BMI 2e-3229 rs858519 4 GCST90012110 no MR -> candidate analysis
Total testosterone levels 1e-758 rs1799941 13 GCST90239819 no MR -> candidate analysis
Bioavailable testosterone levels 8e-309 rs727428 8 GCST90012102 no MR -> candidate analysis
Testosterone levels (UKB data field 30850) 2e-294 rs1799941 2 GCST90468103 no MR -> candidate analysis
Diamine acetyltransferase 2 levels 3e-282 rs858522 3 GCST90247237 no MR -> candidate analysis
Free testosterone levels 1e-233 rs727428 4 GCST90239826 no MR -> candidate analysis
Body fat percentage (adjusted for testosterone and SHBG) 1e-224 rs1799941 15 GCST90432179 no MR -> candidate analysis
N6-acetyllysine levels 9e-176 rs13894 6 GCST90245307 no MR -> candidate analysis
SAT2 protein levels 1e-174 rs148093673 5 GCST90470529 no MR -> candidate analysis
Hypogonadism 1e-136 rs1799941 4 GCST90570530 no MR -> candidate analysis
Blood protein levels 1e-111 rs858519 5 GCST006585 no MR -> candidate analysis
…and 76 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 724 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
testicular disorder 0.726 common-variant locus no MR -> candidate analysis
Abnormality of the skeletal system 0.686 common-variant locus no MR -> candidate analysis
type 2 diabetes mellitus 0.633 common-variant locus no MR -> candidate analysis
smoking cessation 0.499 common-variant locus no MR -> candidate analysis
hypogonadism 0.435 common-variant locus no MR -> candidate analysis
aging 0.463 common-variant locus no MR -> candidate analysis
osteoarthritis, hip 0.385 common-variant locus MR: beta=0.0925, p=0.474 (cis)
atrial fibrillation 0.268 common-variant locus no MR -> candidate analysis

Of the 8 rows above, 7 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Sex hormone-binding globulin)
gnomAD constraint pLI=8.2e-12, LOEUF=1.16 — LoF-tolerant
GWAS Catalog 225 unique SNPs / 584 rows
ClinVar 127 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance